---

$1.39

+0.0400 ( +2.96% ) 35.0K

Rafael Holdings Inc, through its subsidiaries, is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company is a significant investor in two clinical stage oncology companies, Cornerstone Pharmaceuticals, Inc., and LipoMedix Pharmaceuticals Ltd.

Open	$1.39
Previous Close	$1.35
Volume	35.0K
Market Cap	$70.22M
Day Range	$1.33 - $1.40
52 Week Range	$1.12 - $3.19
Shares Outstanding	52.01M
Change %	+2.96%
Net Change	▲ 0.0400
Insider Ownership	-0.03%
Exchange	NYSE
Sector	Miscellaneous
Industry	None
IPO Year	2018
Country	United States

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-02-01	Sale	-348259.00	JONAS HOWARD S
2024-01-18	Sale	-250000.00	GOLDBERG JOHN
2024-01-08	Sale	-27655.00	WEISS MICHAEL J
2024-01-08	Sale	-27655.00	McCamish Mark Anthony
2024-01-08	Sale	-27655.00	GREENBERG STEPHEN M
2023-12-26	Sale	-13602.00	CONKLING WILLIAM
2023-12-26	Sale	-8577.00	Polinsky David
2023-10-26	Sale	-40000.00	CONKLING WILLIAM
2023-10-26	Sale	-40000.00	Polinsky David